In the Northeast, COVID-19 cases appear to be in a plateau, but what does that mean for Southern California?
A former White House COVID advisor told Eyewitness News what he predicts for the summer and fall as a Food and Drug Administration panel voted to grant emergency use authorization for the two-dose Novavax for Americans 18 and older.
He said officials are tracking the upward trends in California. In Los Angeles County, the average number of COVID-positive patients per day is 515, an increase of 118% from one month ago. If L.A. keeps moving toward the highest community threat level, health officials are prepared to re-implement universal indoor mask mandates, which could happen later this month.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
As COVID-19 hospitalizations fall in Northeast, they are rising fast in some states in SouthThe United States is averaging 28,970 COVID-19 hospitalizations a day, up 16% from two weeks ago. Hospitalizations are becoming a better metric to measure the pandemic as so much testing is happening at home and the data are not being collected.
Weiterlesen »
BA.4, BA.5 Variants Rise Among U.S. Covid-19 CasesOmicron Covid-19 variants BA.4 and BA.5 are on the rise in the U.S., adding two more highly contagious versions of the virus to the mix that has fueled a springtime surge in cases
Weiterlesen »
US has wasted more than 82 million COVID-19 vaccine doses: reportMillions of COVID-19 vaccine doses have been discarded during the pandemic as the Biden administration urges Americans to get booster shots
Weiterlesen »
STUDY: Top 10 careers with biggest growth potential, post COVID-19While COVID-19 is still among us, a study by UC San Diego's Center for Research and Evaluation Monday released a list of the top 10 professions with the biggest growth potential in a post or with-COVID world.
Weiterlesen »
J&J Says It Plans to End Covid-19 Vaccine Supply Deal With Emergent BioSolutionsJ&J said it plans to end a Covid-19 vaccine manufacturing contract with Emergent BioSolutions, saying the manufacturer had breached their agreement. The disclosure came after Emergent sued J&J for breach of contract
Weiterlesen »